相关实验视频

Updated: Jun 11, 2025

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

在IVF/ICSI周期中,阿尔法利热与贝塔利热:一项回顾性队列研究

Jing-Xian Cao¹, Jing-Yan Song^2,3

¹Gynecology, Binzhou Hospital of Traditional Chinese Medicine, Binzhou, People's Republic of China.

Drug design, development and therapy

|October 1, 2024

概括

这项研究发现,用于卵巢刺激的Follitropin alpha (Gonal-F) 和Follitropin beta (Puregon) 之间的累积活产率没有显著差异. 这两种治疗方法在实现怀孕结果方面都具有可比的疗效.

科学领域:

生殖医学生殖医学
不孕症治疗不孕症治疗
药理学药理学是指药理学的学科.

背景情况:

不孕症影响人口的很大一部分,需要有效的卵巢刺激策略.
利热素α (Gonal-F) 和利热素β (Puregon) 是常用于诱导排卵的淋巴激素.
对比它们对活产率的疗效对于优化治疗方案至关重要.

研究的目的:

为了比较Follitropin alpha (Gonal-F) 和Follitropin beta (Puregon) 在实现累积活产率 (CLBR) 的疗效.
用这两种淋巴腺激素对卵巢刺激后评估怀孕结果.

主要方法:

一项对2864名接受卵巢刺激的不育患者进行的回顾性队列研究.
倾向分数匹配 (PSM) 和多变量逻辑回归被用来最大限度地减少混因素.
测量的主要结果是Puregon和Gonal-F组之间的CLBR差异.

主要成果:

在PSM之后,每个组的1160名患者的基线特征相似.
在Puregon和Gonal-F组之间的CLBR (52.8%与55.7%,p=0.169) 中没有观察到统计学上显著的差异.
总性腺激素剂量和Gn使用成本显著不同,Gonal-F可能需要更高的剂量,但成本更低.

结论:

在累积活产率方面,利氨酸α (Gonal-F) 和利氨酸β (Puregon) 显示出相似的疗效.
对于担心淋巴激素剂量的患者来说,Gonal-F可能是一个合适的选择,而Puregon则提供了潜在的成本和灵活性优势.
这些发现可以为临床决策和患者咨询提供有关卵巢刺激策略的信息.

关键词:

累积的活产率是指累积的活产率.福利特罗宾阿尔法 (Follitropin Alpha) 是一种药物.福利特罗宾ββ的使用情况在体外受精体外受精.倾向性得分匹配的比分匹配

更多相关视频

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

相关概念视频

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...

Meiosis II

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...